http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102145173-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ca3568dc30a6560d19fcfcf0cc389ef
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb0b2fcdddb9e8ab7529edb42227d175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7328e91baf681a22e1f32108953d04d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0f5d3f7106944c8fac6e0a4bdb38748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2603e6f780bd0f071aa6d7457c362c00
publicationDate 2013-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102145173-B
titleOfInvention Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof
abstract The invention relates to human serum albumin complex hydrophobically modified pullulan nanoparticles and a preparation method thereof. Hydrophobic group cholesterol, pullulan polysaccharides, succinic anhydride and human serum albumin are taken as raw materials for synthesis; the specific synthesis process is as follows: enabling the cholesterol and the succinic anhydride in the mass ratio of (1-2.5): 2 to react to firstly synthesize succinic anhydride cholesterol, and enabling the succinic anhydride cholesterol to react with the pullulan polysaccharides to synthesize cholesterol hydrophobically modified pullulan polysaccharides in the presence of a catalyst, wherein the mass ratio of cholesterol succinate (CHS) to sugar moiety of the pullulan polysaccharides is (1-4): 20; and performing further self-assembly on the hydrophobically modified pullulan polysaccharides to form a solution of the nanoparticles, then incubating the nanoparticles and the human serum albumin in a shaker for 9 hours, and finally getting the human serum albumin complex hydrophobically modified pullulan nanoparticles. The nanoparticles after complexation of the human serum albumin and the hydrophobically modified pullulan polysaccharide nanoparticles are shaped like spheres, and can maintain slow release effect of the medicament-loaded nanoparticles in a long lasting manner and stabilize plasma concentration.
priorityDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11819083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448844975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423512670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13073352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922

Total number of triples: 62.